Pharmaceutical Tablet Supply – Fluconazole 150 mg

The contract solicits the supply of Fluconazole 150 mg tablets in blister strips containing 12 tablets each, with packaging requirements aligned with both commercial and military compliance standards to ensure suitability for delivery to the Defense Logistics Agency. The product must meet stringent quality, labeling, and packaging specifications necessary for use within military medical supply chains, ensuring stability, traceability, and readiness under operational conditions. The solicitation is issued under a subcontract type with a NAICS code of 325412, indicating pharmaceutical manufacturing, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are due by July 28, 2026, with the solicitation posted on July 22, 2026, through the DIBBS platform under reference number SPE2DP26T4241. While no specific set-aside criteria or location details are provided, the place of performance implies nationwide or global distribution channels servicing DLA facilities. Suppliers must be prepared to demonstrate compliance with federal and defense-specific regulatory requirements, including Good Manufacturing Practices, packaging integrity, shelf-life validation, and documentation for military logistics integration. All bids must guarantee consistent supply capability and adherence to timelines to maintain military readiness.